$ 316.73
Updated 08/12/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 754,363
High $ 326.55
Low $ 316.15
Open $ 324.60
ISIN
Prev close $ 326.70
# of shares 201.48M
Market cap 63,816M USD
Intraday

Market closed
Biogen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  316.73 -4.7% Stock price decreasing -2.6% Stock price decreasing -6.9% Stock price decreasing 4.4% Stock price increasing -2.8% Stock price decreasing
Powered by TradingView

News about Biogen Inc

  • English
  • Regulatory news
06 Dec
 
29 Nov
 
29 Oct
 
26 Oct
 
25 Oct
 
23 Oct
 
18 Oct
 
17 Oct
 
11 Oct
 
06 Oct
 

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 69.95 -5.8% Stock price decreasing -3.9% Stock price decreasing 5.1% Stock price increasing 10.6% Stock price increasing 28.0% Stock price increasing 22.6% Stock price increasing
 
Bristol-Myers Squibb Company 53.08 -0.4% Stock price decreasing -0.6% Stock price decreasing -12.8% Stock price decreasing -0.2% Stock price decreasing -15.0% Stock price decreasing -13.4% Stock price decreasing
 
Johnson & Johnson 145.43 -0.5% Stock price decreasing 0.1% Stock price increasing 6.0% Stock price increasing 17.2% Stock price increasing 3.4% Stock price increasing 4.1% Stock price increasing
 
Pfizer Inc 43.92 -4.5% Stock price decreasing -0.8% Stock price decreasing 4.4% Stock price increasing 19.8% Stock price increasing 22.9% Stock price increasing 21.3% Stock price increasing
 
Amgen Inc 191.44 -5.7% Stock price decreasing -0.9% Stock price decreasing -5.5% Stock price decreasing 3.9% Stock price increasing 9.1% Stock price increasing 10.1% Stock price increasing
 
Novartis AG 87.08 -4.8% Stock price decreasing -2.4% Stock price decreasing 5.5% Stock price increasing 15.8% Stock price increasing 3.7% Stock price increasing 3.7% Stock price increasing
 
GlaxoSmithKline PLC 37.30 -3.4% Stock price decreasing -9.7% Stock price decreasing -5.1% Stock price decreasing -9.1% Stock price decreasing 6.1% Stock price increasing 5.2% Stock price increasing
 
Sanofi American Depositary Sha.. 43.48 -2.4% Stock price decreasing -4.6% Stock price decreasing 2.0% Stock price increasing 11.5% Stock price increasing 0.6% Stock price increasing 1.1% Stock price increasing
 
UCB 76.04 1.4% Stock price increasing 0.2% Stock price increasing -2.9% Stock price decreasing 14.9% Stock price increasing 18.7% Stock price increasing 14.9% Stock price increasing
 
Roche Hldg Sp.Adr 1/8 27.75 -2.0% Stock price decreasing 3.6% Stock price increasing 6.1% Stock price increasing 25.0% Stock price increasing 8.5% Stock price increasing 5.6% Stock price increasing
 
Teva Pharmaceutical Industries.. 19.41 -10.1% Stock price decreasing -17.2% Stock price decreasing -7.8% Stock price decreasing -16.0% Stock price decreasing 20.9% Stock price increasing 2.4% Stock price increasing

Company profile

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen markets novel MS drugs Tysabri and Tecfidera independently. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

Peers

Instruments Last Change  
Abbott Labor.. 69.95 -2.2% Stock price decreasing
Bristol-Myer.. 53.08 -0.3% Stock price decreasing
Johnson & Jo.. 145.43 -0.3% Stock price decreasing
Pfizer Inc 43.92 -2.4% Stock price decreasing
Amgen Inc 191.44 0.0% Stock price unchanged
Novartis AG 87.08 -2.2% Stock price decreasing
GlaxoSmithKl.. 37.30 -0.3% Stock price decreasing
Sanofi Ameri.. 43.48 0.0% Stock price unchanged
UCB 76.04 0.8% Stock price increasing
Roche Hldg S.. 27.75 -1.4% Stock price decreasing
Teva Pharmac.. 19.41 -4.2% Stock price decreasing

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
10 December 2018 11:44:51
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB2 - 2018-12-10 12:44:51 - 2018-12-10 11:44:51 - 1000 - Website: OKAY